Header Logo

Susan Zweizig

Concepts (169)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
8
2024
53
1.090
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2025
406
0.650
Why?
Vulvar Neoplasms
2
2014
9
0.560
Why?
Ovarian Neoplasms
8
2025
130
0.530
Why?
Uterine Cervical Neoplasms
4
2005
135
0.470
Why?
Neoplasm Recurrence, Local
5
2024
300
0.450
Why?
Cisplatin
4
2024
119
0.430
Why?
Carcinoma, Squamous Cell
2
2011
237
0.290
Why?
Paclitaxel
2
2025
91
0.270
Why?
Carcinoma, Endometrioid
4
2019
17
0.250
Why?
Sirolimus
2
2016
88
0.230
Why?
Chemoradiotherapy
1
2024
49
0.220
Why?
Female
26
2025
30705
0.200
Why?
Hysterectomy
2
2017
65
0.190
Why?
Carcinoma, Renal Cell
1
2002
83
0.190
Why?
Kidney Neoplasms
1
2002
126
0.180
Why?
Enhancer of Zeste Homolog 2 Protein
1
2019
15
0.170
Why?
Genital Neoplasms, Female
1
1999
17
0.160
Why?
Megestrol Acetate
2
2016
3
0.160
Why?
Tamoxifen
2
2016
35
0.160
Why?
Receptor, Notch2
1
2017
8
0.150
Why?
Humans
26
2025
59360
0.140
Why?
Cervix Uteri
1
1997
56
0.140
Why?
Middle Aged
12
2025
16317
0.130
Why?
Gynecologic Surgical Procedures
2
2014
41
0.130
Why?
Drug Resistance, Neoplasm
3
2025
179
0.130
Why?
Preoperative Care
2
2014
180
0.120
Why?
Aged
10
2025
13416
0.120
Why?
Uterine Prolapse
1
2014
13
0.110
Why?
Colposcopy
1
2014
20
0.110
Why?
Endometrium
1
2014
28
0.110
Why?
Papillomaviridae
1
2014
58
0.110
Why?
Adult
12
2025
15669
0.110
Why?
Anaphylaxis
1
1994
40
0.110
Why?
Mass Screening
1
1999
645
0.110
Why?
Adnexal Diseases
1
1993
8
0.110
Why?
Laparoscopy
1
2017
427
0.110
Why?
Papillomavirus Infections
1
2014
120
0.100
Why?
Postoperative Care
1
2013
114
0.100
Why?
Surgical Procedures, Operative
1
2013
137
0.090
Why?
Herpes Zoster
1
2011
23
0.090
Why?
Recovery of Function
1
2013
270
0.090
Why?
MicroRNAs
1
2017
616
0.090
Why?
Lymphogranuloma Venereum
1
1991
3
0.090
Why?
Risk Factors
3
2014
4984
0.090
Why?
Epothilones
1
2009
1
0.080
Why?
Proto-Oncogene Proteins c-akt
2
2025
188
0.080
Why?
Tubulin Modulators
1
2009
6
0.080
Why?
Tomography, X-Ray Computed
2
2002
1526
0.080
Why?
Peritoneal Neoplasms
1
2009
24
0.080
Why?
Aged, 80 and over
6
2017
5128
0.080
Why?
Mutation
1
2016
2456
0.070
Why?
Postoperative Complications
3
2017
1202
0.070
Why?
Aging
1
2013
710
0.070
Why?
Skin Neoplasms
1
2011
404
0.070
Why?
Neoplasm Staging
3
2019
452
0.060
Why?
Deoxycytidine
1
2005
40
0.060
Why?
Hemangiosarcoma
1
2005
23
0.060
Why?
Biopsy
2
2014
411
0.060
Why?
Brachytherapy
1
2024
38
0.060
Why?
Precancerous Conditions
1
2004
70
0.050
Why?
Prospective Studies
2
2024
3067
0.050
Why?
Neuralgia
1
2003
20
0.050
Why?
Lymph Node Excision
1
2002
38
0.050
Why?
Nephrectomy
1
2002
66
0.050
Why?
Diagnosis, Differential
3
2011
937
0.050
Why?
Filgrastim
1
2020
6
0.040
Why?
Carboplatin
1
2020
40
0.040
Why?
Immunohistochemistry
2
2014
847
0.040
Why?
Struma Ovarii
1
1999
2
0.040
Why?
Thyrotoxicosis
1
1999
7
0.040
Why?
Neoplasm Grading
1
2019
79
0.040
Why?
Prognosis
2
2002
1600
0.040
Why?
Antineoplastic Agents
1
2024
631
0.040
Why?
Genetic Testing
1
1999
126
0.040
Why?
Age Factors
2
2017
1504
0.040
Why?
Proportional Hazards Models
1
2019
674
0.040
Why?
Ileus
1
2017
6
0.040
Why?
Retrospective Studies
4
2017
6071
0.040
Why?
Laparotomy
1
2017
47
0.040
Why?
Uterine Cervical Diseases
1
1997
4
0.040
Why?
Papanicolaou Test
1
1997
42
0.030
Why?
Vaginal Smears
1
1997
54
0.030
Why?
Intraoperative Complications
1
2017
85
0.030
Why?
Neoplasm Invasiveness
1
2017
250
0.030
Why?
Ambulatory Care
1
1999
300
0.030
Why?
Arrhythmias, Cardiac
1
2017
145
0.030
Why?
Venous Thrombosis
1
2017
110
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2016
10
0.030
Why?
Postmenopause
1
1997
224
0.030
Why?
PTEN Phosphohydrolase
1
2016
83
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
170
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2017
475
0.030
Why?
Tumor Suppressor Proteins
1
2016
194
0.030
Why?
Pneumonia
1
2017
281
0.030
Why?
Fatal Outcome
1
1994
116
0.030
Why?
Length of Stay
1
2017
775
0.030
Why?
Ovarian Diseases
2
2004
19
0.030
Why?
Treatment Outcome
2
2020
5284
0.030
Why?
Quality of Life
1
2020
1137
0.030
Why?
Fallopian Tubes
1
1993
11
0.030
Why?
Disease-Free Survival
1
2014
228
0.030
Why?
Torsion Abnormality
1
1993
12
0.030
Why?
Drug Administration Schedule
1
2014
283
0.030
Why?
Neoplasm Metastasis
1
2014
188
0.030
Why?
Ovariectomy
1
1993
96
0.030
Why?
Morbidity
1
1993
112
0.030
Why?
Ovary
1
1993
98
0.030
Why?
Patient Positioning
1
2013
44
0.030
Why?
Carcinoma
1
1993
115
0.030
Why?
Cost-Benefit Analysis
1
2014
297
0.030
Why?
Trophoblastic Neoplasms
1
1992
2
0.020
Why?
Delirium
1
2013
54
0.020
Why?
Forecasting
1
1993
219
0.020
Why?
Decision Support Techniques
1
2014
179
0.020
Why?
Uterine Neoplasms
1
1992
29
0.020
Why?
Wound Healing
1
2013
174
0.020
Why?
Ultrasonography
1
2014
459
0.020
Why?
Pain, Postoperative
1
2013
141
0.020
Why?
Herpesvirus 3, Human
1
2011
9
0.020
Why?
Anti-Bacterial Agents
1
2017
735
0.020
Why?
Follow-Up Studies
1
1997
2337
0.020
Why?
Abdominal Wall
1
2011
21
0.020
Why?
Radiotherapy, Adjuvant
1
2011
58
0.020
Why?
Venous Thromboembolism
1
2013
141
0.020
Why?
Rare Diseases
1
2011
38
0.020
Why?
Pain Management
1
2013
146
0.020
Why?
Cohort Studies
1
1997
2374
0.020
Why?
Biopsy, Needle
1
2011
132
0.020
Why?
Pelvis
1
1991
58
0.020
Why?
Adolescent
3
2004
5824
0.020
Why?
Physical Examination
1
1991
104
0.020
Why?
Lymph Nodes
1
1991
214
0.020
Why?
Bridged-Ring Compounds
1
2009
7
0.020
Why?
Organoplatinum Compounds
1
2009
17
0.020
Why?
Taxoids
1
2009
24
0.020
Why?
Pregnancy
2
1993
2202
0.020
Why?
Patient Discharge
1
2013
489
0.020
Why?
Pregnancy Complications
1
1993
364
0.020
Why?
Mesna
1
2005
3
0.020
Why?
Ifosfamide
1
2005
8
0.020
Why?
Dacarbazine
1
2005
18
0.020
Why?
Chemotherapy, Adjuvant
1
2005
75
0.020
Why?
Doxorubicin
1
2005
97
0.020
Why?
Probability
1
2004
166
0.010
Why?
Child
1
1993
4174
0.010
Why?
Fallopian Tube Diseases
1
2003
5
0.010
Why?
Amitriptyline
1
2003
7
0.010
Why?
Endometriosis
1
2003
24
0.010
Why?
Analgesics, Non-Narcotic
1
2003
35
0.010
Why?
Abscess
1
2003
76
0.010
Why?
Case-Control Studies
1
2004
1051
0.010
Why?
Thyroglobulin
1
1999
9
0.010
Why?
Triiodothyronine
1
1999
26
0.010
Why?
Radionuclide Imaging
1
1999
121
0.010
Why?
Severity of Illness Index
1
2004
1479
0.010
Why?
Risk Assessment
1
2004
1921
0.010
Why?
Cystadenoma
1
1993
6
0.010
Why?
Chromosomes, Human, Pair 11
1
1993
13
0.010
Why?
Chromosome Deletion
1
1993
41
0.010
Why?
Dactinomycin
1
1992
9
0.010
Why?
World Health Organization
1
1992
30
0.010
Why?
Alleles
1
1993
411
0.010
Why?
Cyclophosphamide
1
1992
75
0.010
Why?
Methotrexate
1
1992
76
0.010
Why?
National Institutes of Health (U.S.)
1
1992
111
0.010
Why?
Base Sequence
1
1993
1302
0.010
Why?
Molecular Sequence Data
1
1993
1952
0.010
Why?
United States
1
1992
7390
0.000
Why?
Zweizig's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (169)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_